MMJ PhytoTech Limited (MMJ) owns and is building a diversified portfolio by investing in the full range of emerging cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, R&D and retail.
Peter was appointed as Non-Executive Chairman on 14 August 2014. He is a corporate lawyer and has been a Partner at Steinepreis Paganin (Perth based corporate law firm) since July 2005. Peter graduated from the University of Western Australia in 1998 with a Bachelor of Laws and Bachelor of Commerce (Finance). He has also completed a Masters of Applied Finance and Investment with FINSIA. Peter has a wide range of experience in all forms of commercial and corporate law, with a particular focus on resources (hard rock and oil/gas), equity capital markets and mergers and acquisitions. He also has significant experience in dealing in cross border transactions.
Winton was appointed as Non-Executive Director on 21 October 2014. He is an experienced company director with a broad range of skills and experience in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance. Winton has considerable experience with ASX listed companies and has been involved with many successful ventures from early stage through to large capital development projects. He holds formal qualifications in economics, finance, accounting, education and governance. Winton is a Fellow of the Financial Services Institute of Australasia, a Member of the Australian Institute of Company Directors, a Member of CPA Australia and a Chartered Secretary.
Doug was appointed as Non-Executive Director on 16 March 2018. He is an experienced company director and has also served for 30 years as CFO or CEO in a number of significant and successful (mostly publically-listed) commercial enterprises and investment banks. Doug’s executive experience had a heavy emphasis in corporate strategy, treasury, financial management, M&A and business development. As a professional director he has developed risk management and governance expertise. Doug has a strong background in IPO and start-ups and a reputation for innovation, perseverance and achieving solutions and results. He holds formal qualifications in business administration and accounting and is a Fellow of the Australian Institute of Company Directors.
Jason is an experienced senior executive and board member. He was appointed CEO in February 2018. Prior to joining MMJ, Jason was CFO of DUET Group, a former member of the ASX100, for 9 years to May 2017. As part of this role, he led a significant transformation through M&A, recapitalisations and restructuring that resulted in DUET’s market capitalisation growing from $1.2 billion in 2009 to $7.4 billion in 2017, at which time the group was acquired at an attractive premium. In addition, Jason has gained experience from roles in restructuring, advisory, venture capital, corporate development and corporate finance in Australia and overseas. He holds a Bachelor of Commerce (Accounting), a Master of Business Administration (MBA), is a Fellow of Chartered Accountants Australia and New Zealand (FCA) and a Member of the Australian Institute of Company Directors (MAICD).
Catherine is an experienced pharmaceutical industry executive, with an extensive corporate background, having worked for multiple pharmaceutical organizations both domestically and overseas. Most recently, she held executive leadership positions including Director of Business Development and Corporate Affairs at Mundipharma Pty Limited and Business Development Manager at Nycomed, now Takeda Pharmaceuticals. Throughout her career to date, Catherine has established a strong track record in the implementation of successful commercialisation strategies and strategic planning at senior management level.
She holds a Bachelor of Science in Physiology, Pharmacology and Biochemistry and a Master of Business Law from the University of New South Wales, and is a graduate of the Australian Institute of Company Directors.
Jim has 20 years of experience in the Australian investment management industry with alternative asset fund managers in Australia and overseas including Hastings Funds Management and Annuity Australia. He is a director of Annuity Australia which is an alternative assets fund manager. Jim has been a non-executive director of several businesses in the essential infrastructure, funds management, timberland, agriculture and manufacturing sectors within Australia and the United Kingdom. Jim has a Bachelor Economics, is a member of the Chartered Accountants Australia &New Zealand and a fellow of the Governance Institute of Australia.
Erlyn was appointed as Company Secretary on 1 February 2015. She has a broad range of experience in company administration and corporate governance having held positions as non-executive director and/or company secretary for a number of ASX listed public companies across a range of industries. Erlyn has completed a Bachelor of Commerce (Accounting and Finance) and a Graduate Diploma of Applied Corporate Governance and is an Associate Member of both the Institute of Chartered Secretaries and Administrators and the Governance Institute of Australia.
Debra joined MMJ in March 2018 as Head Office Manager. She has over 20 years of administration experience in legal, risk, compliance and human resources with top 50 ASX companies.
MMJ has adopted comprehensive systems of control and accountability as the basis for the administration of corporate governance. You can download a copy of MMJ’s Corporate Governance Plan here.